Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for FHND1002 Granules assessing safety, tolerability, and pharmacokinetics in healthy adults, with amyotrophic lateral sclerosis l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• FHND1002 Granules

Snippet

Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Status: ENROLLING_BY_INVITATION